Genotype-dependent [18F]FDOPA uptake: quantitative evidence from a genetically stratified PPGL cohort
European Journal of Nuclear Medicine and Molecular Imaging · 2026
DOI: 10.1007/s00259-026-08002-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Paul Dahlmann und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, LMU University Hospital, LMU Munich, 81377, Munich, Germany. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Dihydroxyphenylalanine, Paraganglioma, Pheochromocytoma. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Else Kröner-Fresenius-Stiftung, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
INTRODUCTION: [18F]FDOPA PET/CT is widely used in the diagnostic work-up of pheochromocytoma and paraganglioma (PPGL), with the latter entity classified into genetic clusters 1a, 1b, and 2 and sporadic tumours, reflecting varying aggressiveness. We aimed to assess diagnostic performance and quantitative [18F]FDOPA uptake across genetic clusters. METHODS: Consecutive PPGL patients with [18F]FDOPA PET/CT at initial diagnosis and available information on germline and/or somatic testing were included. Patients were grouped into genetic clusters. PET quantification included metabolic tumour volume (MTV) and maximum SUV(SUVmax), mean SUV(SUVmean) and tumour-to-background ratio (TBR, SUVmax/liver SUVmean). The diameter of the primary was determined on CT. The diagnostic sensitivity for detecting PPGL lesions was assessed visually and with a TBR threshold > 2. Lesion- and patient-based sensitivities were calculated. Subgroups were compared using non-parametric tests with multiplicity control. RESULTS: 69 patients presenting with 86 tumour lesions were analyzed. Patient-based sensitivity was 97.1% (67/69; 95%-CI 89.9-99.7) and lesion-based sensitivity 94.2% (81/86; 95%-CI 87.0-98.1%). Lesion-based sensitivity was 96.3% in non-metastatic disease (77/80; 95%-CI 89.4-99.2%) and 66.7% in metastatic disease [4/6; 95%-CI 22.3-95.7%]). Quantitative analysis showed a high image contrast (median TBR: 6.9). Cluster 2 showed less uptake intensity than sporadic, cluster 1a and cluster 1b tumours (TBR/SUVmean/SUVmax, p = 0.003-0.025). MTV was larger in cluster 1b and sporadic cases than in cluster 2 (p = 0.011-0.018), whereas tumour diameter on CT did not differ between groups (p = 0.086-0.927). CONCLUSION: [18F]FDOPA PET/CT provides excellent image contrast in non-metastasized PPGL and can differentiate between varying genetic clusters, while morphological imaging failed for subtype segregation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, LMU University Hospital, LMU Munich, 81377, Munich, Germany.
- Department of Medicine IV, Endocrinology, Diabetes and Metabolism, LMU University Hospital, LMU Munich, Ziemssenstr. 5, 80336, Munich, Germany.
- Department of Radiology, LMU University Hospital, LMU Munich, 81377, Munich, Germany.
- Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, 8091, Switzerland.
- Department of Nuclear Medicine, LMU University Hospital, LMU Munich, 81377, Munich, Germany. friederike.voelter@med.uni-muenchen.de.
- Department of Medicine IV, Endocrinology, Diabetes and Metabolism, LMU University Hospital, LMU Munich, Ziemssenstr. 5, 80336, Munich, Germany. friederike.voelter@med.uni-muenchen.de.
Förderung
- Else Kröner-Fresenius-Stiftung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Dahlmann, P., Geuss, M., Auer, M., Disko, U., Wang, K., Mansour, N., Schmid-Tannwald, C., Nölting, S., Reisch, N., Reincke, M., Lottspeich, C., Kroiss, M., Werner, R. A., & Völter, F. (2026). Genotype-dependent [18F]FDOPA uptake: quantitative evidence from a genetically stratified PPGL cohort. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-08002-1
Vancouver
Dahlmann P, Geuss M, Auer M, Disko U, Wang K, Mansour N, et al. Genotype-dependent [18F]FDOPA uptake: quantitative evidence from a genetically stratified PPGL cohort. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-08002-1
BibTeX
@article{Dahlmann2026,
author = {Dahlmann, Paul and Geuss, Maria and Auer, Matthias and Disko, Ulrike and Wang, Katharina and Mansour, Nabeel and Schmid-Tannwald, Christine and Nölting, Svenja and Reisch, Nicole and Reincke, Martin and Lottspeich, Christian and Kroiss, Matthias and Werner, Rudolf A and Völter, Friederike},
title = {Genotype-dependent [18F]FDOPA uptake: quantitative evidence from a genetically stratified PPGL cohort},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
doi = {10.1007/s00259-026-08002-1}
}
EUVIMED